214 related articles for article (PubMed ID: 30101912)
1. Glutamic Acid Decarboxylase Autoantibody-negative Slowly Progressive Type 1 Diabetes Mellitus: A Case Report and Literature Review.
Kobayashi M; Ohara N; Ikeda Y; Nagano O; Takada T; Kodama M; Sone H
Intern Med; 2018 Dec; 57(24):3581-3587. PubMed ID: 30101912
[TBL] [Abstract][Full Text] [Related]
2. Rapid Normalization of High Glutamic Acid Decarboxylase Autoantibody Titers and Preserved Endogenous Insulin Secretion in a Patient with Diabetes Mellitus: A Case Report and Literature Review.
Ohara N; Kaneko M; Furukawa T; Koike T; Sone H; Tanaka S; Kaneko K; Kamoi K
Intern Med; 2016; 55(5):485-9. PubMed ID: 26935368
[TBL] [Abstract][Full Text] [Related]
3. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.
Törn C; Landin-Olsson M; Ostman J; Scherstén B; Arnqvist H; Blohmé G; Björk E; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G; Lernmark A
Diabetes Metab Res Rev; 2000; 16(6):442-47. PubMed ID: 11114103
[TBL] [Abstract][Full Text] [Related]
4. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients.
Kasuga A; Maruyama T; Nakamoto S; Ozawa Y; Suzuki Y; Saruta T
J Autoimmun; 1999 Mar; 12(2):131-5. PubMed ID: 10047433
[TBL] [Abstract][Full Text] [Related]
5. Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk.
Miao D; Steck AK; Zhang L; Guyer KM; Jiang L; Armstrong T; Muller SM; Krischer J; Rewers M; Yu L;
Diabetes Technol Ther; 2015 Feb; 17(2):119-27. PubMed ID: 25562486
[TBL] [Abstract][Full Text] [Related]
6. Clinical and genetic characteristics of people with type 1 diabetes who have discrepancies in titers of anti-glutamic acid decarboxylase antibody measured by radioimmunoassay and enzyme-linked immunosorbent assay.
Takagi S; Miura J; Hoshina S; Uchigata Y; Babazono T
J Diabetes Investig; 2020 Mar; 11(2):356-362. PubMed ID: 31267698
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes.
Kawasaki E; Nakamura K; Kuriya G; Satoh T; Kuwahara H; Kobayashi M; Abiru N; Yamasaki H; Eguchi K
J Clin Endocrinol Metab; 2010 Feb; 95(2):707-13. PubMed ID: 20061424
[TBL] [Abstract][Full Text] [Related]
8. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
[TBL] [Abstract][Full Text] [Related]
9. Slowly progressive insulin-dependent (type 1) diabetes positive for anti-GAD antibody ELISA test may be strongly associated with a future insulin-dependent state.
Oikawa Y; Tanaka H; Uchida J; Atsumi Y; Osawa M; Katsuki T; Kawai T; Shimada A
Endocr J; 2017 Feb; 64(2):163-170. PubMed ID: 27760891
[TBL] [Abstract][Full Text] [Related]
10. Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly-progressive type 1 diabetes.
Kawasaki E; Awata T; Ikegami H; Imagawa A; Oikawa Y; Osawa H; Katsuki T; Kanatsuna N; Kawamura R; Kozawa J; Kodani N; Kobayashi T; Shimada A; Shimoda M; Takahashi K; Chujo D; Tsujimoto T; Tsuchiya K; Terakawa A; Terasaki J; Nagasawa K; Noso S; Fukui T; Horie I; Yasuda K; Yasuda H; Yanai H; Hanafusa T; Kajio H;
J Diabetes Investig; 2024 Jul; 15(7):835-842. PubMed ID: 38451108
[TBL] [Abstract][Full Text] [Related]
11. A case of slowly progressive type 1 diabetes with insulin independence maintained for 10 years with α-glucosidase inhibitor monotherapy.
Munakata Y; Yamada T; Takahashi K; Tsukita S; Takahashi K; Sawada S; Imai J; Ishigaki Y; Oka Y; Katagiri H
Intern Med; 2012; 51(24):3391-4. PubMed ID: 23257526
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic autoantibodies in Italian patients with newly diagnosed type 1 diabetes mellitus over the age of 20 years.
Betterle C; Lazzarotto F; Fusari A; Zanchetta R; Benedini S; Pedini B; Moscon A; Presotto F
Acta Diabetol; 2006 Nov; 43(3):79-83. PubMed ID: 17143785
[TBL] [Abstract][Full Text] [Related]
13. Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes.
Giannopoulou EZ; Winkler C; Chmiel R; Matzke C; Scholz M; Beyerlein A; Achenbach P; Bonifacio E; Ziegler AG
Diabetologia; 2015 Oct; 58(10):2317-23. PubMed ID: 26138334
[TBL] [Abstract][Full Text] [Related]
14. LADA and CARDS: a prospective study of clinical outcome in established adult-onset autoimmune diabetes.
Hawa MI; Buchan AP; Ola T; Wun CC; DeMicco DA; Bao W; Betteridge DJ; Durrington PN; Fuller JH; Neil HA; Colhoun H; Leslie RD; Hitman GA
Diabetes Care; 2014 Jun; 37(6):1643-9. PubMed ID: 24722498
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population.
Kukko M; Kimpimäki T; Korhonen S; Kupila A; Simell S; Veijola R; Simell T; Ilonen J; Simell O; Knip M
J Clin Endocrinol Metab; 2005 May; 90(5):2712-7. PubMed ID: 15872335
[TBL] [Abstract][Full Text] [Related]
16. [Autoimmune insulitis in patients with type 2 diabetes mellitus A randomized clinical trial in hospitalized patients].
Martinka E; Rončáková M; Mišániková M; Davani A
Vnitr Lek; 2016; 62(7-8):521-33. PubMed ID: 27627073
[TBL] [Abstract][Full Text] [Related]
17. High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7).
Zampetti S; Campagna G; Tiberti C; Songini M; Arpi ML; De Simone G; Cossu E; Cocco L; Osborn J; Bosi E; Giorgino F; Spoletini M; Buzzetti R;
Eur J Endocrinol; 2014 Dec; 171(6):697-704. PubMed ID: 25213702
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune diabetes in adults: lessons from the UKPDS.
Desai M; Clark A
Diabet Med; 2008 Aug; 25 Suppl 2():30-4. PubMed ID: 18717976
[TBL] [Abstract][Full Text] [Related]
19. The Use of Electrochemiluminescence Assays to Predict Autoantibody and Glycemic Progression Toward Type 1 Diabetes in Individuals with Single Autoantibodies.
Sosenko JM; Yu L; Skyler JS; Krischer JP; Gottlieb PA; Boulware D; Miao D; Palmer JP; Steck AK
Diabetes Technol Ther; 2017 Mar; 19(3):183-187. PubMed ID: 28177779
[TBL] [Abstract][Full Text] [Related]
20. Clinical and biochemical characteristics of nonobese type 2 diabetic patients with glutamic acid decarboxylase antibody in Korea.
Kim CS; Nam JH; Nam JS; Park JS; Kang ES; Ahn CW; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
Metabolism; 2006 Aug; 55(8):1107-12. PubMed ID: 16839848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
